NBS-C (Austria) BioScience

NBS-C (Austria) BioScience offers customized experimental support on a collaboration contract basis. Our portfolio is focused on preclinical development of protein immunotherapeutics, diagnostics and vaccines.

Vela and NBS-C (Austria) BioSciences are working together on non-GMP, R&D projects. This cooperation was initially sparked by a ZIT grant (Call CoOperate Enlarged - Vienna 2008).

Anagnostics GmbH (Austria)

Anagnostics specializes in developing systems and tests for research and clinical multiplex diagnostics. Our aim is to provide solutions for unmet needs especially in the fields of drug research, infectious diseases and diagnostics in the field of oncology. Anagnostics' vision is to establish our proprietary hybcell technology, a breakthrough development in multiplex diagnostics, as an internationally widely accepted standard.

Vela and Anagnostics are working together to establish a GMP-compliant Hyborg system. This project is supported by an FFG COIN grant.